Plain-English translation of NCT05728957 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Doctors sometimes struggle to know whether a kidney tumor is benign (not cancer) or malignant (cancer) just by looking at images. This study is testing whether a special type of imaging scan called 99mTc-sestamibi SPECT/CT, combined with a tumor biopsy, can help doctors accurately figure out what kind of kidney tumor you have before deciding on surgery or other treatment.
Right now, doctors often have to recommend surgery to remove a kidney tumor without being completely certain whether it's cancer or not. The new imaging test being studied here might help doctors make better decisions about treatment and potentially avoid unnecessary surgery for people with benign tumors.
You likely qualify if…
You likely don't qualify if…
You will be asked to fill out a survey about your health and kidney tumor at the beginning and end of the study. You will receive a special imaging scan (99mTc-sestamibi SPECT/CT) to help doctors see your kidney tumor more clearly. You will also have a biopsy of your kidney tumor, where a small sample is taken for testing—this is often done as part of routine care anyway. Finally, you will receive treatment for your kidney tumor as planned by your urologist, and researchers will track how you feel about the decisions you make regarding your care.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States